ABOS
Price
$1.44
Change
+$0.06 (+4.35%)
Updated
Sep 5 closing price
Capitalization
87.23M
72 days until earnings call
LIXT
Price
$4.57
Change
+$0.10 (+2.24%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
20.85M
Interact to see
Advertisement

ABOS vs LIXT

Header iconABOS vs LIXT Comparison
Open Charts ABOS vs LIXTBanner chart's image
Acumen Pharmaceuticals
Price$1.44
Change+$0.06 (+4.35%)
Volume$114.66K
Capitalization87.23M
Lixte Biotechnology Holdings
Price$4.57
Change+$0.10 (+2.24%)
Volume$1.84K
Capitalization20.85M
ABOS vs LIXT Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. LIXT commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and LIXT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ABOS: $1.44 vs. LIXT: $4.57)
Brand notoriety: ABOS and LIXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 31% vs. LIXT: 4%
Market capitalization -- ABOS: $87.23M vs. LIXT: $20.85M
ABOS [@Biotechnology] is valued at $87.23M. LIXT’s [@Biotechnology] market capitalization is $20.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileLIXT’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • LIXT’s FA Score: 0 green, 5 red.
According to our system of comparison, LIXT is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while LIXT’s TA Score has 3 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 4 bearish.
  • LIXT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than LIXT.

Price Growth

ABOS (@Biotechnology) experienced а +5.88% price change this week, while LIXT (@Biotechnology) price change was +2.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABOS($87.2M) has a higher market cap than LIXT($20.8M). LIXT YTD gains are higher at: 120.230 vs. ABOS (-16.279). LIXT has higher annual earnings (EBITDA): -3.08M vs. ABOS (-132.35M). ABOS has more cash in the bank: 143M vs. LIXT (887K). LIXT has less debt than ABOS: LIXT (100K) vs ABOS (30.1M). ABOS (0) and LIXT (0) have equivalent revenues.
ABOSLIXTABOS / LIXT
Capitalization87.2M20.8M419%
EBITDA-132.35M-3.08M4,299%
Gain YTD-16.279120.230-14%
P/E RatioN/AN/A-
Revenue00-
Total Cash143M887K16,122%
Total Debt30.1M100K30,100%
FUNDAMENTALS RATINGS
LIXT: Fundamental Ratings
LIXT
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSLIXT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 19 days ago
78%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXRT34.010.55
+1.64%
NexPoint Residential Trust
GMS109.96N/A
N/A
GMS
EPRX5.36-0.04
-0.74%
Eupraxia Pharmaceuticals
MOGU2.42-0.03
-1.32%
MOGU
CRWV87.48-2.40
-2.67%
Coreweave Inc

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with KYTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+4.35%
KYTX - ABOS
46%
Loosely correlated
+8.54%
CRBU - ABOS
45%
Loosely correlated
+1.08%
GLSI - ABOS
44%
Loosely correlated
-0.36%
BEAM - ABOS
43%
Loosely correlated
+12.62%
CELC - ABOS
43%
Loosely correlated
+2.23%
More

LIXT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIXT has been loosely correlated with LIANY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LIXT jumps, then LIANY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIXT
1D Price
Change %
LIXT100%
-3.25%
LIANY - LIXT
34%
Loosely correlated
+0.38%
PTHS - LIXT
34%
Loosely correlated
+16.87%
ABOS - LIXT
29%
Poorly correlated
-0.72%
NTLA - LIXT
28%
Poorly correlated
-0.77%
IBIO - LIXT
28%
Poorly correlated
-5.53%
More